Sugi Predict

Sugi Predict / Compounds / SCHEMBL7180951

SCHEMBL7180951

SCHEMBL7180951

Cc1cc(C)c(C(=O)[PH](=O)c2c(Cl)c(Cl)c(C(=O)c3ccccc3)c(Cl)c2Cl)c(C)c1C

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 7/20 0.34
▸ MAPT P10636 6/20 0.34
▸ LMNA P02545 4/20 0.34
▸ BCL2L1 Q07817 1/20 0.33
▸ GAA P10253 2/20 0.33
▸ HTT P42858 2/20 0.33
▸ TDP1 Q9NUW8 2/20 0.33
▸ ATM Q13315 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ MEN1 O00255 2/20 0.32
▸ KMT2A Q03164 2/20 0.32
▸ GRM6 O15303 1/20 0.32
▸ CNR2 P34972 1/20 0.32
▸ CHRM4 P08173 1/20 0.32
▸ KDM4E B2RXH2 1/20 0.32
▸ HPGD P15428 2/20 0.32
▸ NPSR1 Q6W5P4 1/20 0.32
▸ PLA2G1B P04054 1/20 0.32
▸ MAPK1 P28482 1/20 0.32
▸ ATG4B Q9Y4P1 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7177974 0.87 TAS1R3 (0.34) ALDH1A1MAPTLMNAHTTATM
SCHEMBL7177494 0.87 TP53 (0.35) ALDH1A1MAPTLMNABCL2L1GAA
SCHEMBL7174833 0.87 KMT2A (0.39) ALDH1A1MAPTLMNABCL2L1GAA
SCHEMBL7180474 0.87 HTT (0.38) ALDH1A1MAPTLMNABCL2L1GAA
SCHEMBL7182791 0.86 TP53 (0.34) ALDH1A1MAPTLMNABCL2L1GAA
SCHEMBL7180520 0.85 ALDH1A1 (0.36) ALDH1A1MAPTLMNABCL2L1GAA
SCHEMBL7177222 0.84 TP53 (0.37) ALDH1A1MAPTLMNAGAAHTT
SCHEMBL7181623 0.84 HTT (0.37) ALDH1A1MAPTLMNABCL2L1GAA
SCHEMBL7182185 0.84 ALDH1A1 (0.38) ALDH1A1MAPTLMNABCL2L1GAA
SCHEMBL7182634 0.84 LMNA (0.36) ALDH1A1MAPTLMNABCL2L1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6579663-B2 Chemical intermediates such as lithium 2,6-dimethylbenzoyl phenylphosphine for preparation of acylphosphines, acylphosphine oxides or acylphosphine sulfides CIBA SPECIALTY CHEMICALS CORPORATION 2003-06-17 — — US disclosed
US-20020107413-A1 Organometallic monoacylarylphosphines WOLF JEAN-PIERRE (CH) 2002-08-08 — — US disclosed
US-6399805-B2 SUCH AS LITHIUM 2,6-DIMETHYLBENZOYLPHENYLPHOSPHINE, USE AS PHOTOINITIATORS IN PHOTOCURABLE COMPOSITIONS SUCH AS FOR PHOTOGRAPHIC PRODUCTION OF RELIEF IMAGES CIBA SPECIALTY CHEMICALS CORPORATION 2002-06-04 — — US disclosed
US-20010031898-A1 Organometallic monoacylarylphosphines CIBA SPECIALTY CHEMICALS CORP. 2001-10-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020107413-A1 Organometallic monoacylarylphosphines CBR1, NAF1, DHCR24 ALDH1A1 3416/4885MAPT 4870/4885LMNA 3241/4885
US-20010031898-A1 Organometallic monoacylarylphosphines NAF1, DHCR24, CBR1 ALDH1A1 3984/4885MAPT 4859/4885LMNA 3247/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.